ChemicalBook--->CAS DataBase List--->2660218-70-0

2660218-70-0

2660218-70-0 Structure

2660218-70-0 Structure
IdentificationBack Directory
[Name]

N-[2-[(3S)-3-(Aminomethyl)-1-piperidinyl]-4-phenoxy-3-(trifluoromethyl)phenyl]-2-(4-pyridazinyl)-4-thiazolecarboxamide
[CAS]

2660218-70-0
[Synonyms]

(S)-N-[2-[3-(Aminomethyl)-1-piperidyl]-4-phenoxy-3-(trifluoromethyl)phenyl]-2-(4-pyridazinyl)thiazole-4-carboxamide
N-[2-[(3S)-3-(Aminomethyl)-1-piperidinyl]-4-phenoxy-3-(trifluoromethyl)phenyl]-2-(4-pyridazinyl)-4-thiazolecarboxamide
[Molecular Formula]

C27H25F3N6O2S
[MOL File]

2660218-70-0.mol
[Molecular Weight]

554.59
Chemical PropertiesBack Directory
[density ]

1.373±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
[pka]

9.46±0.70(Predicted)
Hazard InformationBack Directory
[Uses]

DGKζ-IN-1 (compound 9) is an inhibitor of DGKζ. DGKζ-IN-1 can be used for research in cancer related to immunocyte activation or cancer resistant to anti-PD-1 antibody/anti-PD-L1 antibody[1].
[References]

[1] Watanabe H, et al. Preparation of pyridazinyl-thiazolecarboxamide compound as DGKζ inhibitor. World Intellectual Property Organization, WO2021132422 A1. 2021-07-01.
2660218-70-0 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:2660218-70-0 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.